Institutional Ownership Karyopharm Therapeutics Inc. (KPTI)
This table provides information about the institutional ownership of Karyopharm Therapeutics Inc. (KPTI). We have compiled data on the 98 institutions that hold shares in the stock, with a total of 57.1 Million shares, which have been reported (via 13F filing form) to have a value of $34.8 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
7,654,482
shares
|
$4.75 Million
0.0% of portfolio
|
Q2 2024
Reduced 8.2%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,319,842
shares
|
$3.92 Million
0.01% of portfolio
|
Q4 2024
Added 46.3%
|
|
Palo Alto Investors LP
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
4,907,001
shares
|
$3.04 Million
0.53% of portfolio
|
Q4 2024
Reduced 3.83%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,169,788
shares
|
$2.59 Million
0.0% of portfolio
|
Q2 2024
Reduced 55.86%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
3,513,188
shares
|
$2.18 Million
0.0% of portfolio
|
Q4 2024
Added 2741.3%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
3,103,669
shares
|
$1.92 Million
0.0% of portfolio
|
Q3 2024
Added 0.07%
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
2,401,413
shares
|
$1.49 Million
0.0% of portfolio
|
Q4 2024
Added 15.33%
|
|
Catalio Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,334,375
shares
|
$1.45 Million
0.35% of portfolio
|
Q4 2024
New holding
|
|
Eversept Partners, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,088,757
shares
|
$1.3 Million
0.14% of portfolio
|
Q4 2024
Reduced 62.35%
|
|
Avidity Partners Management LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
2,018,500
shares
|
$1.25 Million
0.16% of portfolio
|
Q2 2024
Reduced 75.68%
|
|
Gsa Capital Partners LLP
London, X0 |
Feb 07, 2025 Q4 2024 |
1,598,435
shares
|
$991,029
0.08% of portfolio
|
Q4 2024
Reduced 9.98%
|
|
C World Wide Group Holding A
|
Feb 04, 2025 Q4 2024 |
1,500,000
shares
|
$930,000
0.01% of portfolio
|
Q4 2021
Added 25.0%
|
|
Ubs Oconnor LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,483,727
shares
|
$919,910
0.07% of portfolio
|
Q4 2024
Added 24.04%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,392,314
shares
|
$863,234
0.0% of portfolio
|
Q4 2024
Added 2.72%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,335,771
shares
|
$828,178
0.0% of portfolio
|
Q4 2024
Reduced 0.07%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
1,268,777
shares
|
$786,641
0.0% of portfolio
|
Q2 2024
Reduced 4.24%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,202,590
shares
|
$745,605
0.0% of portfolio
|
Q4 2024
Reduced 3.13%
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Feb 13, 2025 Q4 2024 |
1,195,293
shares
|
$741,081
0.02% of portfolio
|
Q4 2024
Reduced 0.72%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
1,154,414
shares
|
$715,736
0.0% of portfolio
|
Q4 2024
Reduced 8.03%
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
748,306
shares
|
$463,949
0.0% of portfolio
|
Q4 2024
Added 265.47%
|
|
Altium Capital Management LP
New York, NY |
Feb 13, 2025 Q4 2024 |
740,000
shares
|
$458,800
0.17% of portfolio
|
Q2 2023
Added 46.31%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
664,145
shares
|
$411,769
0.0% of portfolio
|
Q4 2024
Added 119.52%
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
595,990
shares
|
$369,513
0.1% of portfolio
|
Q4 2024
Added 6.72%
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
500,000
shares
|
$310,000
0.0% of portfolio
|
Q3 2024
Reduced 1.12%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
442,510
shares
|
$274,356
0.0% of portfolio
|
Q4 2024
Added 8.06%
|